{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:07:34Z","timestamp":1792919254205,"version":"4.5.0"},"reference-count":71,"publisher":"Society of Nuclear Medicine","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.2967\/jnumed.120.251546","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T17:20:14Z","timestamp":1625592014000},"page":"57S-62S","source":"Crossref","is-referenced-by-count":22,"title":["Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas"],"prefix":"10.2967","volume":"62","author":[{"given":"Waiel A.","family":"Bashari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Senanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"MacFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Powlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Kolias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Mannion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olympia","family":"Koulouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gurnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"2021070610200540000_62.Supplement_2.57S.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.03.001"},{"key":"2021070610200540000_62.Supplement_2.57S.2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000442327","article-title":"Magnetic resonance imaging of pituitary tumors","volume":"45","author":"Bonneville","year":"2016","journal-title":"Front Horm Res."},{"key":"2021070610200540000_62.Supplement_2.57S.3","doi-asserted-by":"crossref","unstructured":"Maya M Pressman BD. Pituitary imaging. In: The Pituitary. 4th ed. 2017:645\u2013669.","DOI":"10.1016\/B978-0-12-804169-7.00023-4"},{"key":"2021070610200540000_62.Supplement_2.57S.4","first-page":"610","article-title":"PET as a tool in the clinical evaluation of pituitary adenomas","volume":"32","author":"Bergstr\u00f6m","year":"1991","journal-title":"J Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-005-1882-0"},{"key":"2021070610200540000_62.Supplement_2.57S.6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3237"},{"key":"2021070610200540000_62.Supplement_2.57S.7","first-page":"1072","article-title":"Insights from growth hormone receptor blockade","volume":"5","author":"Muller","year":"2004","journal-title":"Curr Opin Investig Drugs."},{"key":"2021070610200540000_62.Supplement_2.57S.8","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-10-10"},{"key":"2021070610200540000_62.Supplement_2.57S.9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11102-015-0639-4","article-title":"Pituitary-directed medical therapy in Cushing\u2019s disease","volume":"18","author":"Petersenn","year":"2015","journal-title":"Pituitary."},{"key":"2021070610200540000_62.Supplement_2.57S.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1152"},{"key":"2021070610200540000_62.Supplement_2.57S.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.3.724"},{"key":"2021070610200540000_62.Supplement_2.57S.12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.4.1386"},{"key":"2021070610200540000_62.Supplement_2.57S.13","doi-asserted-by":"crossref","first-page":"1763735","DOI":"10.1155\/2018\/1763735","article-title":"High expression of somatostatin receptors 2A, 3, and 5 in corticotroph pituitary adenoma","volume":"2018","author":"Behling","year":"2018","journal-title":"Int J Endocrinol."},{"key":"2021070610200540000_62.Supplement_2.57S.14","doi-asserted-by":"publisher","DOI":"10.1007\/BF03351043"},{"key":"2021070610200540000_62.Supplement_2.57S.15","first-page":"1184","article-title":"In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man","volume":"32","author":"Bakker","year":"1991","journal-title":"J Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.16","first-page":"652","article-title":"Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide","volume":"33","author":"Krenning","year":"1992","journal-title":"J Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011013231805"},{"key":"2021070610200540000_62.Supplement_2.57S.18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.4.1628"},{"key":"2021070610200540000_62.Supplement_2.57S.19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.6.2356"},{"key":"2021070610200540000_62.Supplement_2.57S.20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.3361119.x"},{"key":"2021070610200540000_62.Supplement_2.57S.21","doi-asserted-by":"publisher","DOI":"10.1007\/BF01390518"},{"key":"2021070610200540000_62.Supplement_2.57S.22","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1360369"},{"key":"2021070610200540000_62.Supplement_2.57S.23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11154-005-5221-3","article-title":"Somatostatin analogs as radiodiagnostic tools","volume":"6","author":"de Herder","year":"2005","journal-title":"Rev Endocr Metab Disord."},{"key":"2021070610200540000_62.Supplement_2.57S.24","first-page":"728","article-title":"Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels","volume":"24","author":"Losa","year":"1997","journal-title":"Eur J Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12020-017-1486-z","article-title":"Use of 111In-pentetreotide scintigraphy for diagnosis and management of resistant macroprolactinoma","volume":"60","author":"Del Gatto","year":"2018","journal-title":"Endocrine."},{"key":"2021070610200540000_62.Supplement_2.57S.26","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347337"},{"key":"2021070610200540000_62.Supplement_2.57S.27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030525"},{"key":"2021070610200540000_62.Supplement_2.57S.28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031812"},{"key":"2021070610200540000_62.Supplement_2.57S.29","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00006231-199812000-00004","article-title":"Pituitary adenomas: the role of 111In-DTPA-octreotide SPET in the detection of minimal post-surgical residues","volume":"19","author":"Lauriero","year":"1998","journal-title":"Nucl Med Commun."},{"key":"2021070610200540000_62.Supplement_2.57S.30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1259\/bjr\/51245688","article-title":"The role of somatostatin receptor scintigraphy in patients with pituitary adenoma or post-surgical recurrent tumours","volume":"78","author":"Acosta-G\u00f3mez","year":"2005","journal-title":"Br J Radiol."},{"key":"2021070610200540000_62.Supplement_2.57S.31","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0076"},{"key":"2021070610200540000_62.Supplement_2.57S.32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cen.14008","article-title":"The clinical impact of [68Ga]-DOTATATE PET\/CT for the diagnosis and management of ectopic adrenocorticotropic hormone\u2013secreting tumours","volume":"91","author":"Wannachalee","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2021070610200540000_62.Supplement_2.57S.33","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.191916"},{"key":"2021070610200540000_62.Supplement_2.57S.34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/RLU.0000000000000457","article-title":"Comparison of 68Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy","volume":"39","author":"Zhao","year":"2014","journal-title":"Clin Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.35","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1097\/RLU.0000000000000462","article-title":"Improvement in diagnosis of metastatic pituitary carcinoma by 68Ga DOTATATE PET\/CT","volume":"40","author":"Xiao","year":"2015","journal-title":"Clin Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/sni.sni_498_16","article-title":"Pituitary carcinoma: a case report and discussion of potential value of combined use of Ga-68 DOTATATE and F-18 FDG PET\/CT scan to better choose therapy","volume":"8","author":"Garmes","year":"2017","journal-title":"Surg Neurol Int."},{"key":"2021070610200540000_62.Supplement_2.57S.37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01080.x"},{"key":"2021070610200540000_62.Supplement_2.57S.38","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-13-2-220"},{"key":"2021070610200540000_62.Supplement_2.57S.39","first-page":"406","article-title":"In vivo measurement of dopamine receptors in pituitary adenomas using positron emission tomography","volume":"369","author":"Muhr","year":"1986","journal-title":"Acta Radiol Suppl."},{"key":"2021070610200540000_62.Supplement_2.57S.40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004728-198603000-00001","article-title":"Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone","volume":"10","author":"Muhr","year":"1986","journal-title":"J Comput Assist Tomogr."},{"key":"2021070610200540000_62.Supplement_2.57S.41","doi-asserted-by":"publisher","DOI":"10.1159\/000095529"},{"key":"2021070610200540000_62.Supplement_2.57S.42","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1097\/RLU.0000000000001721","article-title":"18F-FDOPA PET imaging in prolactinoma","volume":"42","author":"Ginet","year":"2017","journal-title":"Clin Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.43","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1097\/RLU.0000000000002202","article-title":"18F-FDOPA uptake reflects the efficacy of dopamine agonists treatment in pituitary prolactinoma","volume":"43","author":"Heimburger","year":"2018","journal-title":"Clin Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.44","doi-asserted-by":"crossref","first-page":"e1816","DOI":"10.1210\/clinem\/dgaa755","article-title":"Molecular imaging targeting corticotropin releasing hormone receptor for corticotropinoma: a changing paradigm","volume":"106","author":"Walia","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"2021070610200540000_62.Supplement_2.57S.45","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1571-5"},{"key":"2021070610200540000_62.Supplement_2.57S.46","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.083733"},{"key":"2021070610200540000_62.Supplement_2.57S.47","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/RLU.0b013e3182485217","article-title":"A very rare case of nonfunctioning pituitary adenoma incidentally disclosed at 18F-FDG PET\/CT","volume":"37","author":"Maffei","year":"2012","journal-title":"Clin Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/RLU.0b013e3181d19098","article-title":"Occult prolactinoma diagnosed by FDG PET\/CT","volume":"35","author":"Gemmel","year":"2010","journal-title":"Clin Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/0972-3919.84611","article-title":"Incidental detection of clinically occult follicle stimulating hormone secreting pituitary adenoma on whole body 18-Fluorodeoxyglucose positron emission tomography-computed tomography","volume":"26","author":"Joshi","year":"2011","journal-title":"Indian J Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s11102-012-0438-0","article-title":"Acromegaly revealed by 18FDG-PET\/CT in a plasmocytoma patient","volume":"15","author":"Maiza","year":"2012","journal-title":"Pituitary."},{"key":"2021070610200540000_62.Supplement_2.57S.51","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-200203000-00005"},{"key":"2021070610200540000_62.Supplement_2.57S.52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3904\/kjim.2013.28.1.81","article-title":"Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions","volume":"28","author":"Seok","year":"2013","journal-title":"Korean J Intern Med."},{"key":"2021070610200540000_62.Supplement_2.57S.53","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-009-0180-4"},{"key":"2021070610200540000_62.Supplement_2.57S.54","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3171\/2014.10.JNS14911","article-title":"High-resolution18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease","volume":"122","author":"Chittiboina","year":"2015","journal-title":"J Neurosurg."},{"key":"2021070610200540000_62.Supplement_2.57S.55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12020-019-01944-7","article-title":"CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing\u2019s disease","volume":"65","author":"Boyle","year":"2019","journal-title":"Endocrine."},{"key":"2021070610200540000_62.Supplement_2.57S.56","first-page":"44","article-title":"Dynamic 13N-ammonia PET: a new imaging method to diagnose hypopituitarism","volume":"46","author":"Xiangsong","year":"2005","journal-title":"J Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.57","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.acra.2018.09.015","article-title":"Utility of 13N-ammonia PET\/CT to detect pituitary tissue in patients with pituitary adenomas","volume":"26","author":"Wang","year":"2019","journal-title":"Acad Radiol."},{"key":"2021070610200540000_62.Supplement_2.57S.58","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/MNM.0000000000000372","article-title":"Multicenter study evaluating extraprostatic uptake of 11C-choline, 18F-methylcholine, and 18F-ethylcholine in male patients: physiological distribution, statistical differences, imaging pearls, and normal variants","volume":"36","author":"Haroon","year":"2015","journal-title":"Nucl Med Commun."},{"key":"2021070610200540000_62.Supplement_2.57S.59","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e328330adc5"},{"key":"2021070610200540000_62.Supplement_2.57S.60","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1097\/RLU.0000000000001328","article-title":"Pituitary non-functioning adenoma disclosed at 18F-choline PET\/CT to investigate a prostate cancer relapse","volume":"41","author":"Maffione","year":"2016","journal-title":"Clin Nucl Med."},{"key":"2021070610200540000_62.Supplement_2.57S.61","first-page":"250","article-title":"Incidental pituitary adenoma detected by 18 F-FDG PET\/CT and 18 F-choline PET\/CT in the same patient","volume":"37","author":"Albano","year":"2018","journal-title":"Rev Esp Med Nucl Imagen Mol."},{"key":"2021070610200540000_62.Supplement_2.57S.62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.14740\/jem300w","article-title":"18F-choline PET\/CT as a new tool for functional imaging of non-proliferating secreting neuroendocrine tumors","volume":"5","author":"van der Hiel","year":"2015","journal-title":"J Endocrinol Metab."},{"key":"2021070610200540000_62.Supplement_2.57S.63","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0616"},{"key":"2021070610200540000_62.Supplement_2.57S.64","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001085"},{"key":"2021070610200540000_62.Supplement_2.57S.65","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0639"},{"key":"2021070610200540000_62.Supplement_2.57S.66","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0284185116651005","article-title":"Accumulation of 11 C-methionine in the normal pituitary gland on 11 C-methionine PET","volume":"58","author":"Tomura","year":"2017","journal-title":"Acta Radiol."},{"key":"2021070610200540000_62.Supplement_2.57S.67","doi-asserted-by":"publisher","DOI":"10.3171\/2009.7.JNS09285"},{"key":"2021070610200540000_62.Supplement_2.57S.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2013.11.011"},{"key":"2021070610200540000_62.Supplement_2.57S.69","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00259-008-1008-6","article-title":"PET\/MRI system design","volume":"36","author":"Delso","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021070610200540000_62.Supplement_2.57S.70","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2020.3.FOCUS2052","article-title":"PET-guided repeat transsphenoidal surgery for previously deemed unresectable lateral disease in acromegaly","volume":"48","author":"Bashari","year":"2020","journal-title":"Neurosurg Focus."},{"key":"2021070610200540000_62.Supplement_2.57S.71","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S2213-8587(16)30311-4","article-title":"Localisation of an occult thyrotropinoma with 11 C-methionine PET-CT before and after somatostatin analogue therapy","volume":"4","author":"Koulouri","year":"2016","journal-title":"Lancet Diabetes Endocrinol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.251546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T13:22:06Z","timestamp":1725369726000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.251546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":71,"journal-issue":{"issue":"Supplement 2","published-online":{"date-parts":[[2021,7,6]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.2967\/jnumed.120.251546"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.251546","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}